Antibody-Drug Conjugates

Italian drugmaker commits to ADC development

Menarini forms ADC manufacturing deal with OBT

By Gareth Macdonald

Menarini has committed millions of euros to an antibody drug conjugate (ADC) clinical development and manufacturing pact with Oxford BioTerapeutics (OBT). 

Follow us

Products

View more

Webinars